Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
PSPluristem Therapeutics Inc. logo

Pluristem Therapeutics Inc. (PSTI)

NASDAQ Global Market · Currency in USD
$1.00 ▼ -0.03 (-2.91%)
At close: Jul 26, 12:00 AM ET. Market closed.

Summary

Previous Close
$1.03
Open
$1.02
Day's Range
$0.96 – $1.04
52 Week Range
--
Volume
170,627
Avg. Volume
104,540
Market Cap
$40.85M
Beta (5Y Monthly)
1.91
PE Ratio (TTM)
--
EPS (TTM)
-$2.60
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Pluristem Therapeutics Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
153
CEO
Yaky Yanay

Pluristem Therapeutics Inc., an Israeli biotechnology firm founded in 2001 and based in Haifa, specializes in the discovery, advancement, clinical assessment, and production of innovative cell-based therapeutic products. The company's primary focus is on addressing a spectrum of severe medical conditions, including those related to reduced blood flow (ischemia), inflammation, blood disorders, and autoimmune dysfunctions, using its proprietary technologies. A cornerstone of their product pipeline involves placental expanded (PLX) based cell therapies.

Earnings

DateEst.Actual
Sep 12, 2022-$0.02-$0.49Miss
May 9, 2022-$0.36-$0.31Beat
Mar 31, 2022–-$0.31
Feb 7, 2022-$0.38-$0.34Beat
Dec 31, 2021–-$0.34
Nov 8, 2021-$0.41-$0.36Beat

Analyst view

Rating: Buy
Buy 80% · Hold 20% · Sell 0%

Get free alerts on PSTI and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.